Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany

Tatjana Schwarz, Pinkus Tober-Lau, David Hillus, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Willi Koch, Irmgard Landgraf, Janine Michel, Leon Bergfeld, Daniela Niemeyer, Barbara Mühlemann, Claudia Conrad, Chantip Dang-Heine, Stefanie Kasper, Friederike Münn, Kai Kappert, Andreas Nitsche, Rudolf Tauber, Sein SchmidtPiotr Kopankiewicz, Harald Bias, Joachim Seybold, Christof von Kalle, Terry C. Jones, Norbert Suttorp, Christian Drosten, Leif Erik Sander*, Victor M. Corman*, Florian Kurth*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

57 Citations (Scopus)

Abstract

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (median age 34 years) in Germany. These data emphasize that nonpharmaceutical interventions for coronavirus disease remain crucial and that additional immunizations for the elderly might become necessary.

Original languageEnglish
Pages (from-to)2174-2178
Number of pages5
JournalEmerging Infectious Diseases
Volume27
Issue number8
DOIs
Publication statusPublished - Aug 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany'. Together they form a unique fingerprint.

Cite this